diethylnitrosamine has been researched along with Alloxan Diabetes in 9 studies
Diethylnitrosamine: A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties.
N-nitrosodiethylamine : A nitrosamine that is N-ethylethanamine substituted by a nitroso group at the N-atom.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Metformin, which is widely used in the treatment of diabetes, ameliorates insulin sensitivity." | 3.81 | Metformin suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-+Leprdb/+Leprdb mice. ( Baba, A; Kochi, T; Kubota, M; Moriwaki, H; Ohno, T; Shimizu, M; Shirakami, Y; Tanaka, T; Tsurumi, H, 2015) |
| ") injection of diethylnitrosamine (DEN) (125 mg kg(-1) body weight) at week 4 followed by promotion with streptozotocin (STZ) (65 mg kg(-1) body weight with a single i." | 3.71 | 1alpha,25-Dihydroxyvitamin D(3) inhibits rat liver ultrastructural changes and the development of gamma-glutamyltranspeptidase-positive foci in diethylnitrosamine-initiated and streptozotocin-induced diabetes-promoted hepatocarcinogenesis. ( Bhattacharya, R; Chatterjee, M; Saha, BK, 2002) |
| "In addition, type 1 diabetes mellitus (T1DM) is also characterized by a proinflammatory state and by requiring insulin exogenous treatment." | 1.48 | Diethylnitrosamine Increases Proliferation in Early Stages of Hepatic Carcinogenesis in Insulin-Treated Type 1 Diabetic Mice. ( Álvarez, ML; Arboatti, AS; Carnovale, CE; Francés, DEA; Lambertucci, F; Monti, J; Pisani, G; Ronco, MT; Sedlmeier, MG, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arboatti, AS | 1 |
| Lambertucci, F | 1 |
| Sedlmeier, MG | 1 |
| Pisani, G | 1 |
| Monti, J | 1 |
| Álvarez, ML | 1 |
| Francés, DEA | 1 |
| Ronco, MT | 1 |
| Carnovale, CE | 1 |
| Das, BK | 1 |
| Choukimath, SM | 1 |
| Gadad, PC | 1 |
| Ohno, T | 2 |
| Shimizu, M | 3 |
| Shirakami, Y | 3 |
| Baba, A | 2 |
| Kochi, T | 2 |
| Kubota, M | 3 |
| Tsurumi, H | 1 |
| Tanaka, T | 3 |
| Moriwaki, H | 3 |
| Miyazaki, T | 1 |
| Ideta, T | 1 |
| Sakai, H | 2 |
| Yasuda, Y | 1 |
| Terakura, D | 1 |
| Hara, Y | 1 |
| Abdel-Hamid, NM | 1 |
| Nazmy, MH | 1 |
| Abdel-Bakey, AI | 1 |
| Saha, BK | 2 |
| Bhattacharya, R | 1 |
| Chatterjee, M | 2 |
| Sarkar, A | 1 |
| Basak, R | 1 |
| Columbano, A | 1 |
| Dessì, S | 1 |
| Ledda-Columbano, GM | 1 |
| Chiodino, C | 1 |
| Coni, P | 1 |
| Pani, P | 1 |
| Rao, KN | 1 |
9 other studies available for diethylnitrosamine and Alloxan Diabetes
| Article | Year |
|---|---|
Diethylnitrosamine Increases Proliferation in Early Stages of Hepatic Carcinogenesis in Insulin-Treated Type 1 Diabetic Mice.
Topics: Animals; Carcinoma, Hepatocellular; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Me | 2018 |
Asarone and metformin delays experimentally induced hepatocellular carcinoma in diabetic milieu.
Topics: Allylbenzene Derivatives; Animals; Anisoles; Carcinoma, Hepatocellular; Diabetes Mellitus, Experimen | 2019 |
Metformin suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-+Leprdb/+Leprdb mice.
Topics: Adipokines; Animals; Animals, Newborn; Carcinogenesis; Diabetes Mellitus, Experimental; Diethylnitro | 2015 |
Sodium alginate prevents progression of non-alcoholic steatohepatitis and liver carcinogenesis in obese and diabetic mice.
Topics: Alginates; Animals; Cell Transformation, Neoplastic; Diabetes Mellitus, Experimental; Diethylnitrosa | 2016 |
Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db Mice.
Topics: Adenoma; Animals; Anticarcinogenic Agents; Carcinogens; Catechin; Diabetes Mellitus, Experimental; D | 2011 |
Polyol profile as an early diagnostic and prognostic marker in natural product chemoprevention of hepatocellular carcinoma in diabetic rats.
Topics: Aldehyde Reductase; Allyl Compounds; alpha-Fetoproteins; Animals; Ascorbic Acid; Blood Glucose; Carc | 2011 |
1alpha,25-Dihydroxyvitamin D(3) inhibits rat liver ultrastructural changes and the development of gamma-glutamyltranspeptidase-positive foci in diethylnitrosamine-initiated and streptozotocin-induced diabetes-promoted hepatocarcinogenesis.
Topics: Animals; Body Weight; Calcitriol; Cytoplasm; Diabetes Mellitus, Experimental; Diethylnitrosamine; En | 2002 |
1alpha, 25-Dihydroxyvitamin D3 suppresses the effect of streptozotocin-induced diabetes during chemical rat liver carcinogenesis.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Antioxidants; Blood Glucose; Cytochrome P-450 Enz | 2001 |
HMP-shunt and cholesterol metabolism in experimental models involving normal and preneoplastic liver growth.
Topics: Animals; Cell Division; Cholesterol; Diabetes Mellitus, Experimental; Diethylnitrosamine; Fasting; G | 1987 |